- Home
- MTLS vs LXEO Comparison
MTLS vs LXEO Comparison
Compare MTLS & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- LXEO
- Stock Information
- Founded
- MTLS 1990
- LXEO 2017
- Country
- MTLS Belgium
- LXEO United States
- Employees
- MTLS N/A
- LXEO N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- LXEO
- Sector
- MTLS Technology
- LXEO
- Exchange
- MTLS Nasdaq
- LXEO Nasdaq
- Market Cap
- MTLS 349.7M
- LXEO 290.5M
- IPO Year
- MTLS 2014
- LXEO 2023
- Fundamental
- Price
- MTLS $6.40
- LXEO $10.01
- Analyst Decision
- MTLS
- LXEO Strong Buy
- Analyst Count
- MTLS 0
- LXEO 8
- Target Price
- MTLS N/A
- LXEO $18.13
- AVG Volume (30 Days)
- MTLS 210.9K
- LXEO 1.6M
- Earning Date
- MTLS 10-28-2025
- LXEO 11-14-2025
- Dividend Yield
- MTLS N/A
- LXEO N/A
- EPS Growth
- MTLS N/A
- LXEO N/A
- EPS
- MTLS 0.09
- LXEO N/A
- Revenue
- MTLS $308,751,613.00
- LXEO N/A
- Revenue This Year
- MTLS $2.98
- LXEO N/A
- Revenue Next Year
- MTLS $7.09
- LXEO N/A
- P/E Ratio
- MTLS $72.76
- LXEO N/A
- Revenue Growth
- MTLS N/A
- LXEO N/A
- 52 Week Low
- MTLS $3.93
- LXEO $1.45
- 52 Week High
- MTLS $9.69
- LXEO $11.72
- Technical
- Relative Strength Index (RSI)
- MTLS 60.38
- LXEO 68.49
- Support Level
- MTLS $5.45
- LXEO $8.65
- Resistance Level
- MTLS $6.25
- LXEO $10.38
- Average True Range (ATR)
- MTLS 0.34
- LXEO 0.72
- MACD
- MTLS -0.04
- LXEO -0.02
- Stochastic Oscillator
- MTLS 100.00
- LXEO 85.08
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.